Tag: Benzodiazepine

Deafening Silence: What Happens When the Whistle Blows and Nobody Hears?

64
September 11th 2015 was my last day working as a counselor/therapist in the U.S. community mental health system. After 22 years working within that system I resigned out of protest having waged a concerted effort (2½ years) to challenge potentially dangerous psychiatric drug prescribing patterns at my workplace. In late April of this year these challenges led to the filing of a major complaint with the Massachusetts Dept. of Mental Health and eventually the Dept. of Public Health. I never expected to discover just HOW unprepared, dysfunctional, and totally oblivious the entire state bureaucracy is when it involves any serious complaints detailing possible abuses and harm being done to its citizens by a branch of medicine called Psychiatry. Just how broken is "Broken"?

Still Mistreating the Elderly with Psychiatric Drugs: Benzodiazepines

27
Despite safety concerns, a new study reveals that there has been no change in the use of benzodiazepines in the elderly from 2001 to 2010.

UK Woman Speaks Out About 22 Year Addiction With Prescribed Ativan

3
ITV features and article and video today about the widespread problem of addiction and withdrawal from benzodiazepine drugs used to treat anxiety, including Ativan, Librium, Diazepam and Temazepam. Mother of three Sandra Minshull shares her story and discusses how Ativan “robbed her of her life.”

Benzodiazepines Linked to Treatment Resistant Depression

8
Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.

Benzodiazepines: Psychiatry’s Weakest Link  

38
Benzodiazepines may be the most popular, widely used, and immediately effective of all the psychiatric drugs. At the same time they are perhaps one of the most dangerous, addictive, and abused mind-altering substances on the planet. Since the 1980’s psychiatry and their partners in the pharmaceutical industry have spent billions of dollars marketing these drugs and justifying their efficacy in the “treatment” of anxiety and insomnia. Psychiatry has been able to create a patient base of millions of people who are dependent on these drugs and are forced to remain “co-dependent” customers of psychiatrists and other medical doctors in order to procure them.